Carolina Garcia Rizo, PhD, MBA, is a multilingual global business developer with expertise in leveraging ML/AI to drive sustainable growth in healthcare, biotech, and diagnostics. With a background in Atomic and Molecular Physics and a Fulbright Scholar, she is a thought leader in precision medicine and has made significant contributions to drug discovery and development. Carolina is currantly involved in multiple drug discovery, biotech and AI startups including Modulus Therapeutics, QuantPi, Rarebase, Oisin Biotechnologies, and EVEXIA Bio Fund.